Tibor Keler is CSO & VP at Celldex Therapeutics, Inc. (CLDX). They have made 6 open-market trades across 1 company since 2010, most recently 2022-12-07.
CIK 0001429931
5 open-market purchases totalling $65K since 2010, against 1 sale. Across 5 scored buys the stock is up 25.9% at ninety days, and 23.0 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CLDX | 7,357 | $203K |
Shares reported on the most recent Form 4, priced at the 2022-12-09 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 40% |
| Avg Move | +23.1% | +32.4% | +25.9% |
| Alpha | +26.2% | +31.7% | +23.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLDX | SELL | 2022-12-07 | 2022-12-09 | $36.93 | $1.2M | +20.2% | +21.4% | +19.7% |
| CLDX | BUY | 2020-06-09 | 2020-06-10 | $2.99 | $15K | +188.9% | +161.3% | +154.8% |
| CLDX | BUY | 2018-06-15 | 2018-06-18 | $0.59 | $10K | -17.0% | -15.0% | -29.7% |
| CLDX | BUY | 2016-09-02 | 2016-09-06 | $3.32 | $10K | +3.4% | +19.0% | +7.4% |
| CLDX | BUY | 2011-08-11 | 2011-08-11 | $2.50 | $13K | -29.9% | -1.6% | -1.6% |
| CLDX | BUY | 2010-09-13 | 2010-09-13 | $3.52 | $18K | -29.9% | -1.6% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.